Kääpä Biotech is a Finnish biotechnological company that utilizes and works with fungi for healthier humans and ecosystems. Find out more about Kääpä Biotech at: http://kaapabiotech.com/
Innovation Manager successfully helped Kääpä Biotech to close a Series A round and raise private investments from business angels in Europe.
Kääpä Biotech will use the fresh new capital injection to further bringing fungal inventions to the market, strengthen the team and beef up international sales.
“As a 1st time CEO of a fast growing startup here in Finland my personal network of investors and angels is quite limited. Innovation Manager supported this weakness by connecting me with experienced individuals all over the EU who supported our recent 600k raise. I can’t recommend their services enough, quick and professional.”– Eric Puuro (Kääpä Biotech CEO)
Innovation Manager can help you get more investor meetings and raise the capital you need faster! Here is how we do it:
- We develop compelling investor material, such as pitch decks, one-pagers, financial models and demo videos.
- We send out weekly investors’ marketing campaigns to selected contacts and our database of ~6000 vetted business angels, family offices and early-stage VCs in the whole Nordics, Baltics, Germany and Netherlands.
- We collect investors’ feedback and arrange meetings for you. Already after 2 weeks we will send you a detailed report with recommendations and give you a list of leads.
You will pay us only a success fee, as a percentage of all final funds secured for you – no equity nor retainer fees.
Our dealflow includes 45+ high-tech startups from Finland with a ticket size between €50k – €1.5M (Pre-Seed/Seed) or €1.5M+ (Series A).
Get in touch with us to find out more.